News & Updates

Multipronged approach pushed to optimize statin therapy in Singapore

16 Sep 2023 by

There are several important barriers to statin therapy optimization among patients with hyperlipidaemia who are at very high risk of cardiovascular disease (CVD), as reported by a group of local researchers.

Multipronged approach pushed to optimize statin therapy in Singapore

16 Sep 2023

Twice-daily deferasirox effective, well-tolerated in paediatric thalassaemia patients

16 Sep 2023

Treatment with deferasirox twice daily, compared with a once-daily regimen, results in significant improvements in the iron chelation efficacy and tolerability among transfusion-dependent paediatric beta-thalassaemia patients, a study has shown.

Twice-daily deferasirox effective, well-tolerated in paediatric thalassaemia patients

16 Sep 2023

SLE rash treatment better with GC plus hydroxychloroquine combo vs GC monotherapy

16 Sep 2023

Combination treatment with glucocorticoid (GC) plus hydroxychloroquine appears to yield more favourable outcomes than GC alone in the treatment of systemic lupus erythematosus (SLE) rash, while having a good safety profile, according to a study.

SLE rash treatment better with GC plus hydroxychloroquine combo vs GC monotherapy

16 Sep 2023

Extended clopidogrel monotherapy after DAPT reduces bleeding events in ‘bi-risk’ ACS patients

16 Sep 2023 by

Extended clopidogrel monotherapy after a 9- to 12-month course of dual antiplatelet therapy (DAPT) reduces bleeding and ischaemic events in patients with acute coronary syndrome (ACS) who are at high risk for both events, according to the OPT-BIRISK* trial presented at ESC 2023.

Extended clopidogrel monotherapy after DAPT reduces bleeding events in ‘bi-risk’ ACS patients

16 Sep 2023

Common antihypertensive drug linked to glaucoma

15 Sep 2023 by

The use of calcium channel blockers (CCBs) may contribute to an increased risk of glaucoma despite CCBs having no effect on intraocular pressure (IOP), according to a large study.

Common antihypertensive drug linked to glaucoma

15 Sep 2023

COSMIC-313 highlights benefit of triplet regimen in RCC

15 Sep 2023 by

In the COSMIC-313 trial, the addition of the tyrosine kinase inhibitor (TKI) cabozantinib to the immune checkpoint inhibitor (ICI)-doublet regimen comprising nivolumab and ipilimumab (NIVO/IPI) improved progression-free survival (PFS) in patients with previously untreated, advanced renal-cell carcinoma (RCC) who had intermediate or poor prognostic risk according to the IMDC* category.

COSMIC-313 highlights benefit of triplet regimen in RCC

15 Sep 2023

COVID-19 booster may cause transient glycaemic elevations in T1D

15 Sep 2023

Individuals with type 1 diabetes (T1D) may experience mild, temporary glycaemic elevations following receipt of a COVID-19 booster vaccine, according to a study.

COVID-19 booster may cause transient glycaemic elevations in T1D

15 Sep 2023

Original New Drug Application Approvals by US FDA (01-15 September 2023)

15 Sep 2023

New drug applications approved by US FDA as of 01-15 September 2023 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original New Drug Application Approvals by US FDA (01-15 September 2023)

15 Sep 2023

Mpox vax holds up against severe infection

14 Sep 2023 by

Individuals who have received mpox vaccination or have been previously exposed to mpox infection, which is used to be called monkeypox, appear to be better protected against severe disease from a subsequent infection, as shown in a study.

Mpox vax holds up against severe infection

14 Sep 2023

Oral antipsychotics show similar safety profile in older adults after major surgery

14 Sep 2023

Comparisons of atypical antipsychotics and haloperidol reveal similar rates of in-hospital adverse clinical events in older patients with postoperative delirium who have taken an oral low-to-moderate dose antipsychotic drug, a study has shown.

Oral antipsychotics show similar safety profile in older adults after major surgery

14 Sep 2023

News & Updates

Filter by Specialty:

Specialty:

Multipronged approach pushed to optimize statin therapy in Singapore

Multipronged approach pushed to optimize statin therapy in Singapore

Twice-daily deferasirox effective, well-tolerated in paediatric thalassaemia patients

Twice-daily deferasirox effective, well-tolerated in paediatric thalassaemia patients

SLE rash treatment better with GC plus hydroxychloroquine combo vs GC monotherapy

SLE rash treatment better with GC plus hydroxychloroquine combo vs GC monotherapy

Extended clopidogrel monotherapy after DAPT reduces bleeding events in ‘bi-risk’ ACS patients

Extended clopidogrel monotherapy after DAPT reduces bleeding events in ‘bi-risk’ ACS patients

Common antihypertensive drug linked to glaucoma

Common antihypertensive drug linked to glaucoma

COSMIC-313 highlights benefit of triplet regimen in RCC

COSMIC-313 highlights benefit of triplet regimen in RCC

COVID-19 booster may cause transient glycaemic elevations in T1D

COVID-19 booster may cause transient glycaemic elevations in T1D

Original New Drug Application Approvals by US FDA (01-15 September 2023)

Original New Drug Application Approvals by US FDA (01-15 September 2023)

Mpox vax holds up against severe infection

Mpox vax holds up against severe infection

Oral antipsychotics show similar safety profile in older adults after major surgery

Oral antipsychotics show similar safety profile in older adults after major surgery